Showing 1 - 7 results of 7 for search 'Maria Judit Molnar', query time: 0.02s Refine Results
  1. 1
    Answer to Gerber et al. “Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy”

    Answer to Gerber et al. “Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy” by Anikó Gál, Janine H Santos, Mária Judit Molnár, György Hajnóczky

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Insights into eye genetics and recent advances in ocular gene therapy

    Insights into eye genetics and recent advances in ocular gene therapy by Viktória Szabó, Balázs Varsányi, Mirella Barboni, Ágnes Takács, Krisztina Knézy, Mária Judit Molnár, Zoltán Zsolt Nagy, Bence György, Carlo Rivolta

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Erratum To: MSTO1 is a cytoplasmic pro‐mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans

    Erratum To: MSTO1 is a cytoplasmic pro‐mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans by Aniko Gal, Peter Balicza, David Weaver, Shamim Naghdi, Suresh K Joseph, Péter Várnai, Tibor Gyuris, Attila Horváth, Laszlo Nagy, Erin L Seifert, Maria Judit Molnar, György Hajnóczky

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson’s Disease in the Hungarian Population

    The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson’s Disease in the Hungarian Population by Sándor Márki, Anikó Göblös, Eszter Szlávicz, Nóra Török, Péter Balicza, Benjamin Bereznai, Annamária Takáts, József Engelhardt, Péter Klivényi, László Vécsei, Mária Judit Molnár, Nikoletta Nagy, Márta Széll

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    MSTO1 is a cytoplasmic pro‐mitochondrial fusion protein

    MSTO1 is a cytoplasmic pro‐mitochondrial fusion protein by Aniko Gal, Peter Balicza, David Weaver, Shamim Naghdi, Suresh K Joseph, Péter Várnai, Tibor Gyuris, Attila Horváth, Laszlo Nagy, Erin L Seifert, Maria Judit Molnar, György Hajnóczky

    Published 2017-05-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Results of the Hungarian Newborn Screening Pilot Program for Spinal Muscular Atrophy

    Results of the Hungarian Newborn Screening Pilot Program for Spinal Muscular Atrophy by Krisztina Hegedűs, István Lénárt, Andrea Xue, Péter Béla Monostori, Ákos Baráth, Borbála Mikos, Szabolcs Udvari, Adrienn Géresi, Attila József Szabó, Csaba Bereczki, Mária Judit Molnár, Ildikó Szatmári

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial

    Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial by Amel Karaa, Enrico Bertini, Valerio Carelli, Bruce Cohen, Gregory M. Ennes, Marni J. Falk, Amy Goldstein, Gráinne Gorman, Richard Haas, Michio Hirano, Thomas Klopstock, Mary Kay Koenig, Cornelia Kornblum, Costanza Lamperti, Anna Lehman, Nicola Longo, Maria Judit Molnar, Sumit Parikh, Han Phan, Robert D. S. Pitceathly, Russekk Saneto, Fernando Scaglia, Serenella Servidei, Mark Tarnopolsky, Antonio Toscano, Johan L. K. Van Hove, John Vissing, Jerry Vockley, Jeffrey S. Finman, Anthony Abbruscato, David A. Brown, Alana Sullivan, James A. Shiffer, Michelango Mancuso, on behalf of the MMPOWER-3 Trial Investigators

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: